GLI Supports the Bipartisan Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., July 8, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and...
Treatment Strategies and Advancements in TestingGlobal Liver Institute brings you key updates on emerging treatment strategies and advocacy efforts from global leaders like the World Hepatitis...
Global Research and Patient Priorities Emphasizing the Importance of Using Patient-Reported Data at the DIA 2025 Conference, Washington, D.C. Kristin Hatcher, Director of GLI’s...
Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American CommunitiesInfection with hepatitis B poses a serious risk to the health of many Americans – especially in certain...
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development(Washington, D.C. June 24, 2025) – At the Global Liver Institute, we believe that it all...
TROA Reintroduced, Veterans Health Advances, Hep C Bill Introduced, and Senate Considers Medicaid Cuts The House passed H.R. 1, the One Big, Beautiful Bill Act, sending the budget reconciliation...
GLI Works With Congress to Protect Veterans’ Health(Washington, D.C., June 11, 2025) – Global Liver Institute (GLI), in close coordination with congressional staff, has worked tirelessly to ensure...
Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health ConversationGlobal Liver Institute Calls for Urgent Action as Fatty Liver Disease Prevalence Surges Worldwide (Washington,...
GLI Supports the Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., June 9, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce...
Hep C Elimination Bill - Statement of Support Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to...
Recent News
Congress Begins Work to Advance Appropriations Bills, Looks Ahead to Possible Package of Health Policies GLI was pleased to see liver health priorities included in appropriations bills and intends to push Congress to take action on other pending health policy...
United Voices for Liver HealthA Note from the Director, Dr. Sharon H. Jaycox Advocacy in Liver Disease: Bridging Knowledge, Empathy, and Action Uniting Patients and Doctors Through Education and Shared Experience I recently participated in a retreat alongside several...
Advocacy in Action: A Global Call to Address Liver CancerA Note from the Liver Cancers Program Director, Sarah Manes As the Liver Cancers Program Director at Global Liver Institute, I’m proud to share two important milestones in liver cancer advocacy that emphasize...
Driving Progress in Rare Liver Disease Patient Story Feature: From Patient to Pioneer: Frans Frielink’s Journey with Alpha-1 MZ When years of fatigue, inflammation, and unanswered symptoms left him without a diagnosis, Frans Frielink, an engineer by...
From Patient to Pioneer: Frans Frielink’s Journey with Alpha-1 MZMy name is Frans Frielink, and I have over 40 years of experience in the semiconductor market in research and business. My background is deeply rooted in analytical thinking, problem-solving, and...
